Authors: Elting, LS Rubenstein, EB Martin, CG Kurtin, D Rodriguez, S Laiho, E Kanesan, K Cantor, SB Benjamin, RS

Citation: Ls. Elting et al., Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia, J CL ONCOL, 19(4), 2001, pp. 1137-1146

Authors: Escalante, CP Kurtin, D Rivera, E Elting, LS

Citation: Cp. Escalante et al., Severity of illness, outcomes, and resource use in elderly cancer patientswith deep venous thrombosis, CL APPL T-H, 6(3), 2000, pp. 175-178

Authors: Elting, LS Rubenstein, EB Rolston, K Cantor, SB Martin, CG Kurtin, D Rodriguez, S Lam, T Kanesan, K Bodey, G

Citation: Ls. Elting et al., Time to clinical response: An outcome of antibiotic therapy of febrile neutropenia with implications for quality and cost of care, J CL ONCOL, 18(21), 2000, pp. 3699-3706

Authors: Elting, LS Rubenstein, EB Kurtin, D Rolston, KVI Fangtang, J Martin, CG Raad, II Whimbey, EE Manzullo, E Bodey, GP

Citation: Ls. Elting et al., Mississippi mud in the 1990s - Risks and outcomes of vancomycin-associatedtoxicity in general oncology practice, CANCER, 83(12), 1998, pp. 2597-2607